REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.05
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.57

07 Jul
2026

-0.170

OPEN

$6.61

-2.52%

HIGH

$6.76

488,428

LOW

$6.51

TARGET
$8.033 22.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA . RYM . SNZ .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 16.3 17.8 xxx
DPS (cps) xxx 16.2 17.6 xxx
EPS Growth xxx N/A 9.3% xxx
DPS Growth xxx 25.5% 8.5% xxx
PE Ratio xxx N/A 35.3 xxx
Dividend Yield xxx N/A 2.8% xxx
Div Pay Ratio(%) xxx 99.8% 99.1% xxx

Dividend yield today if purchased 3 years ago: 7.37%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.58

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/09 - ex-div 9.13c (franking 70%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx16.3
DPS All xxxxxxxxxxxxxxx16.2
Sales/Revenue xxxxxxxxxxxxxxx1,152.8 M
Book Value Per Share xxxxxxxxxxxxxxx-5.6
Net Operating Cash Flow xxxxxxxxxxxxxxx306.1 M
Net Profit Margin xxxxxxxxxxxxxxx4.25 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-
Return on Invested Capital xxxxxxxxxxxxxxx-
Return on Assets xxxxxxxxxxxxxxx2.50 %
Return on Equity xxxxxxxxxxxxxxx-
Return on Total Capital xxxxxxxxxxxxxxx-
Free Cash Flow ex dividends xxxxxxxxxxxxxxx175.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx4 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx445 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx192 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx86.5 M
Capex % of Sales xxxxxxxxxxxxxxx7.50 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,011 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx90 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx124 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxxxx xxxxxxxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

30/04/2026

1

Buy

$8.60

30.90%

Ord Minnett notes the Commonwealth has released its independent review of residential aged care accommodation pricing and announced a $3bn funding package to be included in the May budget.

The broker finds the most material recommendations include an updated accommodation supplement framework and deregulation of the DAP (daily accommodation payment) rate.

Accommodation funding is becoming the primary driver of returns in the medium term, the broker adds, driven by RAD (refundable accommodation deposit) retention and higher DAP income.

Buy rating retained. Target rises to $8.60 from $8.40.

FORECAST
Ord Minnett forecasts a full year FY26 dividend of 17.30 cents and EPS of 18.10 cents.
Ord Minnett forecasts a full year FY27 dividend of 24.30 cents and EPS of 24.20 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

22/06/2026

3

Downgrade to Neutral from Overweight

$7.50

14.16%

Jarden downgrades Regis Healthcare to Neutral from Overweight with its target price decreased to $7.50 following a regulatory review of recent sector legislative shifts.

Industry channel checks reveal that initial adoption rates for the Higher Everyday Living Fee voluntary package remain less robust than previously modeled, as macro cost-of-living pressures prompt incoming residents to opt out.

The analyst notes this operational headwind is further compounded by a delayed implementation timeline for federal accommodation supplement increases, which are deferred to March 2027 due to government software bottlenecks.

Revisions drive a -11.3% reduction to FY27 diluted EPS forecasts and a -14.3% drop for FY28 to encapsulate the slowed funding transitions.

Commentary concludes long-term corporate value remains supported by severe macro bed supply deficits, which will eventually catalyse structural accommodation pricing power once immediate legislative head-winds clear.

FORECAST
Jarden forecasts a full year FY26 dividend of 18.00 cents and EPS of 18.40 cents.
Jarden forecasts a full year FY27 dividend of 20.60 cents and EPS of 23.50 cents.

REG STOCK CHART